ClinicalTrials.Veeva

Menu

Comparative Study Between One-Shot Dilatation Versus Serial Dilatation Techniques for Access in Percutaneous Nephrolithotomy in Adult Patients

A

Ain Shams University

Status

Completed

Conditions

Renal Stone Disease
Percutaneous Nephrolithotomy (PCNL)

Treatments

Procedure: renal dilatation by metallic telescopic dilators (Alken).
Procedure: renal dilatation by sequential fascial dilators (Amplatz)
Procedure: renal dilatation by one-shot dilatation technique

Study type

Interventional

Funder types

Other

Identifiers

NCT07279389
FMASU MS133/2022

Details and patient eligibility

About

This comparative study aims to compare and assess the safety, efficacy, outcome, feasibility, intraoperative and postoperative complications of one-shot dilatation versus serial dilatation techniques for access during percutaneous nephrolithotomy for management of renal stone disease in adult patients.

Enrollment

60 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged between 18 and 70 years.
  • Patients with renal stones which their size in maximum diameter is more than 2cm and indicated for percutaneous nephrolithotomy.
  • Patients clinically fit for surgery.
  • Patients with normal anatomy of urinary tract.
  • Patients able to understand the procedure and accept to sign the informed consent.

Exclusion criteria

  • Patients aged below 18 or above 70 years.
  • Patients with renal stones which their size in maximum diameter is less than 2cm or contraindicated for endoscopic management.
  • Patients with urinary tract infection, abnormal coagulopathy state or clinically unfit for surgery.
  • Patients with nephrostomy tube in situ.
  • Patients with more than single access tract.
  • Patients undergoing simultaneous bilateral stone procedures.
  • Patients with urinary tract abnormalities or history of renal transplantation.
  • Renal insufficiency with serum creatinine above 3.0mg/dL
  • Patients unable to understand the procedure or refuse to sign the informed consent.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 3 patient groups

Patients receiving renal dilatation by one-shot dilatation technique
Active Comparator group
Description:
renal dilatation was done by one-shot dilatation technique using 30Fr Amplatz dilator directly over the central Alken rod.
Treatment:
Procedure: renal dilatation by one-shot dilatation technique
Patients receiving renal dilatation by metallic telescopic dilators (Alken).
Active Comparator group
Treatment:
Procedure: renal dilatation by metallic telescopic dilators (Alken).
Patients receiving renal dilatation by sequential fascial dilators (Amplatz).
Active Comparator group
Treatment:
Procedure: renal dilatation by sequential fascial dilators (Amplatz)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems